Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Total Articles

14
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

Rapivab

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Comparison chart: Antiviral drugs for influenza for 2023-2024. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2023;65:e1-e6. [PMID: 37935021 DOI: 10.58347/tml.2023.1689e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/09/2023] Abstract Collapse Key Words Rapivab Relenza Tamiflu Xofluza adverse effects antivirals baloxavir dosage drug interactions efficacy influenza lactation oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Humans Antiviral Agents/adverse effects Influenza, Human/drug therapy Enzyme Inhibitors/therapeutic use Neuraminidase Oseltamivir/therapeutic use Zanamivir/therapeutic use Collapse Grants Collapse
2	Antiviral drugs for influenza for 2023-2024. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2023;65:177-182. [PMID: 37935018 DOI: 10.58347/tml.2023.1689a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/09/2023] Abstract Collapse Key Words Rapivab Relenza Tamiflu Xofluza adverse effects antivirals baloxavir dosage drug interactions efficacy influenza lactation oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Humans Antiviral Agents/adverse effects Influenza, Human/drug therapy Enzyme Inhibitors/therapeutic use Neuraminidase Oseltamivir/therapeutic use Zanamivir/therapeutic use Collapse Grants Collapse
3	Influenza vaccine for 2023-2024. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2023;65:161-166. [PMID: 37871115 DOI: 10.58347/tml.2023.1687a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2023] Abstract Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication.1,2 Influenza vaccines that are available in the US for the 2023-2024 season are listed in Table 2. Collapse Key Words Afluria FluLaval FluMist Fluad Fluarix Flublok FluceIvax Fluzone Fluzone High-Dose Heplisav-B Rapivab Relenza Shingrix Tamiflu Xofluza adverse effects antivirals baloxavir drug interactions efficacy influenza influenza vaccine oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Humans Influenza Vaccines Influenza, Human/drug therapy Antiviral Agents/therapeutic use Oseltamivir/therapeutic use Neuraminidase Enzyme Inhibitors/therapeutic use Collapse Grants Collapse
4	Antiviral drugs for influenza for 2022-2023. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2022;64:185-190. [PMID: 36397189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023] Abstract Collapse Key Words FluMist Rapivab Relenza Tamiflu Xofluza adverse effects amantadine antiviral drugs baloxavir dosage drug interactions efficacy influenza influenza vaccine lactation oseltamivir peramivir pregnancy rimantadine safety zanamivir Collapse MESH Headings Humans Antiviral Agents/therapeutic use Influenza, Human/drug therapy Collapse Grants Collapse
5	Comparison chart: Antiviral drugs for influenza for 2022-2023. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2022;64:e1-e5. [PMID: 36397192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023] Abstract Collapse Key Words FluMist Rapivab Relenza Tamiflu Xofluza adverse effects antiviral drugs baloxavir dosage drug interactions influenza influenza vaccine lactation oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Humans Antiviral Agents/therapeutic use Influenza, Human/drug therapy Collapse Grants Collapse
6	Influenza vaccine for 2022-2023. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2022;64:153-157. [PMID: 36206165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023] Abstract Collapse Key Words Afluria FluLaval FluMist Fluad Fluarix Flublok FluceIvax Fluzone Fluzone High-Dose Heplisav-B Rapivab Relenza Shingrix Tamiflu Xofluza adverse effects baloxavir dosage efficacy influenza influenza vaccine oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/therapeutic use Enzyme Inhibitors/therapeutic use Humans Influenza A virus Influenza Vaccines Influenza, Human/drug therapy Neuraminidase Oseltamivir/therapeutic use Collapse Grants Collapse
7	Influenza vaccine for 2021-2022. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2021;63:153-157. [PMID: 34550956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023] Abstract Collapse Key Words Afluria FluLaval FluMist Fluad Fluarix Flublok FluceIvax Fluzone Fluzone High-Dose Heplisav-B Influvac Rapivab Relenza Shingrix Tamiflu Xofluza adverse effects antivirals baloxavir dosage efficacy influenza influenza vaccine oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Age Factors Double-Blind Method Drug Approval Humans Influenza A virus Influenza B virus Influenza Vaccines/administration & dosage Influenza, Human/prevention & control Randomized Controlled Trials as Topic United States United States Food and Drug Administration Vaccines, Combined Collapse Grants Collapse
8	Antiviral drugs for influenza for 2020-2021. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:169-172. [PMID: 33429402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023] Abstract Collapse Key Words FluMist Rapivab Relenza Tamiflu Xofluza adverse effects amantadine antiviral drugs baloxavir coronavirus dosage drug interactions efficacy influenza influenza vaccine lactation neuraminidase inhibitors oseltamivir peramivir pregnancy rimantadine safety zanamivir Collapse MESH Headings Antiviral Agents/administration & dosage Antiviral Agents/adverse effects Antiviral Agents/therapeutic use Drug Interactions Drug Resistance, Viral Enzyme Inhibitors/administration & dosage Enzyme Inhibitors/adverse effects Enzyme Inhibitors/therapeutic use Humans Influenza, Human/complications Influenza, Human/drug therapy Influenza, Human/prevention & control Neuraminidase/antagonists & inhibitors Risk Factors SARS-CoV-2 COVID-19 Drug Treatment Collapse Grants Collapse
9	Expanded table: Antiviral drugs for influenza. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:e2-e4. [PMID: 33429406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023] Abstract Collapse Key Words Rapivab Relenza Tamiflu Xofluza adverse effects antiviral drugs baloxavir dosage drug interactions efficacy influenza lactation oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/therapeutic use Drug Resistance, Viral/drug effects Humans Influenza, Human/drug therapy Collapse Grants Collapse
10	Expanded table: antiviral drugs for influenza (online only). THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:e9-e10. [PMID: 31999664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023] Abstract Collapse Key Words Rapivab Relenza Tamiflu Xofluza adverse effects baloxavir marboxil dosage drug interactions efficacy lactation oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/administration & dosage Antiviral Agents/therapeutic use Drug Interactions Humans Influenza, Human/drug therapy Collapse Grants Collapse
11	Antiviral drugs for influenza. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:1-4. [PMID: 31999661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023] Abstract Collapse Key Words FluMist Rapivab Relenza Tamiflu Xofluza adverse effects antiviral drugs baloxavir marboxil dosage drug interactions efficacy influenza influenza vaccine lactation oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/administration & dosage Antiviral Agents/adverse effects Antiviral Agents/therapeutic use Drug Interactions Humans Influenza A virus/drug effects Influenza, Human/drug therapy Influenza, Human/prevention & control Influenza, Human/virology Collapse Grants Collapse
12	Expanded table: Antiviral drugs for treatment and prophylaxis of seasonal influenza 2018-2019. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2019;61:e11-e12. [PMID: 30681664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Abstract Collapse Key Words Rapivab Relenza Tamiflu Xofluza adverse effects baloxavir marboxil dosage drug interactions efficacy influenza oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/administration & dosage Antiviral Agents/adverse effects Drug Interactions Drug Resistance, Viral Humans Influenza, Human/diagnosis Influenza, Human/drug therapy Influenza, Human/epidemiology Influenza, Human/virology Orthomyxoviridae/drug effects Orthomyxoviridae/pathogenicity Risk Factors Treatment Outcome Collapse Grants Collapse
13	Antiviral drugs for treatment and prophylaxis of seasonal influenza. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2019;61:1-4. [PMID: 30681660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Abstract Collapse Key Words Flumist Rapivab Relenza Tamiflu Xofluza adverse effects baloxavir marboxil dosage drug interactions efficacy influenza influenza vaccine oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/administration & dosage Antiviral Agents/adverse effects Clinical Decision-Making Drug Interactions Drug Resistance, Viral Humans Influenza, Human/diagnosis Influenza, Human/drug therapy Influenza, Human/epidemiology Influenza, Human/virology Orthomyxoviridae/drug effects Orthomyxoviridae/pathogenicity Patient Selection Risk Factors Seasons Treatment Outcome Collapse Grants Collapse
14	Baloxavir marboxil (Xofluza) for treatment of influenza. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2018;60:193-196. [PMID: 30653474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Abstract Collapse Key Words Rapivab Relenza Tamiflu Xofluza adverse effects baloxavir marboxil dosage drug interactions efficacy influenza neuraminidase inhibitors oseltamivir peramivir pregnancy safety zanamivir Collapse MESH Headings Antiviral Agents/administration & dosage Antiviral Agents/adverse effects Dibenzothiepins Drug Interactions Drug Resistance, Viral Enzyme Inhibitors/administration & dosage Enzyme Inhibitors/adverse effects Humans Influenza A virus/drug effects Influenza A virus/enzymology Influenza B virus/drug effects Influenza B virus/enzymology Influenza, Human/diagnosis Influenza, Human/drug therapy Influenza, Human/virology Morpholines Neuraminidase/antagonists & inhibitors Neuraminidase/metabolism Oxazines/administration & dosage Oxazines/adverse effects Pyridines/administration & dosage Pyridines/adverse effects Pyridones Thiepins/administration & dosage Thiepins/adverse effects Treatment Outcome Triazines/administration & dosage Triazines/adverse effects Viral Proteins/antagonists & inhibitors Viral Proteins/metabolism Collapse Grants Collapse